WHITEHAWK THERAPEUTICS, INC. (WHWK) Return on equity 2018–2025
WHITEHAWK THERAPEUTICS, INC. (WHWK) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-15.1%FY2025 · since FY2018: -17.7% → -15.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -15.1% | +106.3 pp |
| FY2024 | -121.4% | -58.8 pp |
| FY2023 | -62.5% | -24.3 pp |
| FY2022 | -38.2% | +42.5 pp |
| FY2021 | -80.7% | — |
| FY2018 | -17.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More WHWK financial trends
WHWK RevenueWHWK Net incomeWHWK Net marginWHWK Gross profitWHWK Gross marginWHWK Operating incomeWHWK Operating marginWHWK Operating cash flowWHWK Free cash flowWHWK Capital expendituresWHWK Stock buybacksWHWK Dividends paidWHWK Total assetsWHWK Total liabilitiesWHWK Shareholders’ equityWHWK overview →